503 related articles for article (PubMed ID: 34997266)
1. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
[TBL] [Abstract][Full Text] [Related]
2. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.
Qu X; Zhai B; Liu Y; Chen Y; Xie Z; Wang Q; Wu Y; Liu Z; Chen J; Mei S; Wu J; You Z; Yu Y; Wang Y
Biomed Pharmacother; 2022 Jun; 150():112998. PubMed ID: 35489281
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
[TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation.
Zhang J; Wang G; Shi Y; Liu X; Liu S; Chen W; Ning Y; Cao Y; Zhao Y; Li M
Cardiovasc Diabetol; 2024 May; 23(1):160. PubMed ID: 38715043
[TBL] [Abstract][Full Text] [Related]
5. LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR.
Xu Y; Fang H; Xu Q; Xu C; Yang L; Huang C
Cell Cycle; 2020 Nov; 19(22):3054-3065. PubMed ID: 33092444
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of ROS/Chloride Efflux-Mediated NLRP3 Inflammasome Activation Contributes to Alleviation of Diabetic Cardiomyopathy in Rats after Sleeve Gastrectomy.
Li S; Dong S; Shi B; Xu Q; Li L; Wang S; Zhang W; Zhong M; Zhu J; Cheng Y; Zhang G; Hu S
Oxid Med Cell Longev; 2022; 2022():4608914. PubMed ID: 35498125
[TBL] [Abstract][Full Text] [Related]
7. Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways.
Yao J; Li Y; Jin Y; Chen Y; Tian L; He W
Int Immunopharmacol; 2021 Jul; 96():107728. PubMed ID: 33971494
[TBL] [Abstract][Full Text] [Related]
8. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Li A; Lv J; Sun X; Che H; Han T; Meng S; Bai Y; Wang L
Cell Physiol Biochem; 2018; 50(4):1230-1244. PubMed ID: 30355944
[TBL] [Abstract][Full Text] [Related]
9. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy.
Yang F; Qin Y; Lv J; Wang Y; Che H; Chen X; Jiang Y; Li A; Sun X; Yue E; Ren L; Li Y; Bai Y; Wang L
Cell Death Dis; 2018 Sep; 9(10):1000. PubMed ID: 30250027
[TBL] [Abstract][Full Text] [Related]
10. Ameliorate effect of pyrroloquinoline quinone against cyclophosphamide-induced nephrotoxicity by activating the Nrf2 pathway and inhibiting the NLRP3 pathway.
Lin X; Yang F; Huang J; Jiang S; Tang Y; Li J
Life Sci; 2020 Sep; 256():117901. PubMed ID: 32504759
[TBL] [Abstract][Full Text] [Related]
11. BMP-7 Attenuates Inflammation-Induced Pyroptosis and Improves Cardiac Repair in Diabetic Cardiomyopathy.
Elmadbouh I; Singla DK
Cells; 2021 Oct; 10(10):. PubMed ID: 34685620
[TBL] [Abstract][Full Text] [Related]
12. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
[TBL] [Abstract][Full Text] [Related]
13. MG53 protects against Coxsackievirus B3-induced acute viral myocarditis in mice by inhibiting NLRP3 inflammasome-mediated pyroptosis via the NF-κB signaling pathway.
Xue Y; Song T; Ke J; Lin S; Zhang J; Chen Y; Wang J; Fan Q; Chen F
Biochem Pharmacol; 2024 May; 223():116173. PubMed ID: 38552849
[TBL] [Abstract][Full Text] [Related]
14. Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome.
Peng M; Liu Y; Xu Y; Li L; Li Y; Yang H
Cell Cycle; 2021 Nov; 20(21):2278-2290. PubMed ID: 34585633
[TBL] [Abstract][Full Text] [Related]
15. Exogenous Spermidine Alleviates Diabetic Myocardial Fibrosis Via Suppressing Inflammation and Pyroptosis in db/db Mice.
Wei C; Xu J; Liu Y; Qadir J; Zhang S; Yuan H
Balkan Med J; 2023 Sep; 40(5):333-343. PubMed ID: 37350700
[TBL] [Abstract][Full Text] [Related]
16. Protective role of hydrogen sulfide against diabetic cardiomyopathy by inhibiting pyroptosis and myocardial fibrosis.
Liu M; Zeng C; Zhang Y; Xin Y; Deng S; Hu X
Biomed Pharmacother; 2024 Jun; 175():116613. PubMed ID: 38657502
[TBL] [Abstract][Full Text] [Related]
17. Pyrroloquinoline quinone attenuates isoproterenol hydrochloride‑induced cardiac hypertrophy in AC16 cells by inhibiting the NF‑κB signaling pathway.
Wen J; Shen J; Zhou Y; Zhao X; Dai Z; Jin Y
Int J Mol Med; 2020 Mar; 45(3):873-885. PubMed ID: 31922230
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
19. Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-mediated NLRP3 inflammasome and TGF-β1/Smads signaling in diabetic cardiomyopathy.
Che H; Wang Y; Li H; Li Y; Sahil A; Lv J; Liu Y; Yang Z; Dong R; Xue H; Wang L
FASEB J; 2020 Apr; 34(4):5282-5298. PubMed ID: 32067273
[TBL] [Abstract][Full Text] [Related]
20. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
Liu X; Guo B; Zhang W; Ma B; Li Y
J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
